IL64243A - Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them - Google Patents

Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them

Info

Publication number
IL64243A
IL64243A IL64243A IL6424381A IL64243A IL 64243 A IL64243 A IL 64243A IL 64243 A IL64243 A IL 64243A IL 6424381 A IL6424381 A IL 6424381A IL 64243 A IL64243 A IL 64243A
Authority
IL
Israel
Prior art keywords
human leukocyte
preparation
pharmaceutical compositions
compositions containing
genetic engineering
Prior art date
Application number
IL64243A
Other languages
English (en)
Other versions
IL64243A0 (en
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL64243A0 publication Critical patent/IL64243A0/xx
Publication of IL64243A publication Critical patent/IL64243A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL64243A 1980-11-10 1981-11-09 Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them IL64243A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons

Publications (2)

Publication Number Publication Date
IL64243A0 IL64243A0 (en) 1982-02-28
IL64243A true IL64243A (en) 1985-11-29

Family

ID=27394813

Family Applications (1)

Application Number Title Priority Date Filing Date
IL64243A IL64243A (en) 1980-11-10 1981-11-09 Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them

Country Status (34)

Country Link
EP (1) EP0051873B1 (ja)
JP (1) JP2642291B2 (ja)
KR (1) KR920007439B1 (ja)
AT (1) ATE46718T1 (ja)
AU (1) AU555293B2 (ja)
BR (1) BR8107293A (ja)
CA (2) CA1212915A (ja)
CH (2) CH663032A5 (ja)
DE (2) DE3144469A1 (ja)
DK (1) DK173590B1 (ja)
DO (1) DOP1981004064A (ja)
DZ (1) DZ350A1 (ja)
ES (2) ES8302778A1 (ja)
FI (1) FI79550C (ja)
FR (1) FR2493867B1 (ja)
GB (1) GB2090258B (ja)
GR (1) GR81947B (ja)
HK (1) HK51685A (ja)
IE (1) IE51850B1 (ja)
IL (1) IL64243A (ja)
IT (1) IT1169276B (ja)
KE (1) KE3536A (ja)
LU (1) LU83745A1 (ja)
MC (1) MC1424A1 (ja)
MY (2) MY8700710A (ja)
NL (1) NL189092C (ja)
NO (1) NO165201C (ja)
NZ (1) NZ198906A (ja)
PH (1) PH18565A (ja)
PL (1) PL233748A1 (ja)
PT (1) PT73955B (ja)
SE (1) SE460539B (ja)
YU (1) YU46597B (ja)
ZW (1) ZW26981A1 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
EP0085693A1 (en) * 1981-08-14 1983-08-17 A/S Alfred Benzon Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
EP0072541A3 (en) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
WO1983002461A1 (en) * 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
JPS60500574A (ja) * 1983-02-24 1985-04-25 インステイチユト　オルガニチエスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスア−ル ヒト白血球インタ−フェロンｎ及び細菌細胞におけるその製造方法
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (en) * 1984-08-31 1986-03-12 University Patents, Inc. Hybrid lymphoblastoid-leukocyte human interferons
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3685996T2 (de) * 1985-06-11 1993-01-14 Ciba Geigy Ag Hybrid-interferone.
WO1987002037A1 (en) * 1985-09-26 1987-04-09 Genetics Institute, Inc. Pulmonary surfactant proteins
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
EP0830368A1 (en) 1995-06-07 1998-03-25 Genta Incorporated Novel carbamate-based cationic lipids
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
EP1539960B1 (en) 2002-09-09 2010-04-28 Hanall Pharmaceutical Co., Ltd. Protease-resistant modified interferon alpha polypeptides
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
JP2008507298A (ja) 2004-05-19 2008-03-13 マキシジェン， インコーポレイテッド インターフェロンαポリペプチドおよび結合体
WO2007044083A2 (en) 2005-05-18 2007-04-19 Maxygen, Inc. Evolved interferon-alpha polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO164037C (no) * 1980-01-08 1990-08-22 Biogen Inc Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type.

Also Published As

Publication number Publication date
CA1212915A (en) 1986-10-21
KR830007825A (ko) 1983-11-07
CH663032A5 (de) 1987-11-13
PH18565A (en) 1985-08-09
FR2493867A1 (fr) 1982-05-14
CH660743A5 (de) 1987-06-15
ES506955A0 (es) 1983-02-01
ATE46718T1 (de) 1989-10-15
DK494681A (da) 1982-05-11
ES512354A0 (es) 1983-03-01
NL189092B (nl) 1992-08-03
NO165201B (no) 1990-10-01
FI79550C (fi) 1990-01-10
LU83745A1 (de) 1983-09-01
ES8302778A1 (es) 1983-02-01
AU555293B2 (en) 1986-09-18
DOP1981004064A (es) 1988-03-16
MC1424A1 (fr) 1982-10-18
IL64243A0 (en) 1982-02-28
NO813785L (no) 1982-05-11
NL189092C (nl) 1993-01-04
ES8304200A1 (es) 1983-03-01
DE3144469A1 (de) 1982-09-02
ZW26981A1 (en) 1982-06-02
MY8800066A (en) 1988-12-31
FI813539L (fi) 1982-05-11
IE812622L (en) 1982-05-10
KR920007439B1 (ko) 1992-09-01
IE51850B1 (en) 1987-04-15
EP0051873B1 (en) 1989-09-27
DZ350A1 (fr) 2004-09-13
EP0051873A2 (en) 1982-05-19
PL233748A1 (en) 1983-07-18
YU265681A (en) 1984-08-31
BR8107293A (pt) 1982-08-03
IT1169276B (it) 1987-05-27
DK173590B1 (da) 2001-04-02
DE3177106D1 (en) 1989-11-02
PT73955A (en) 1981-12-01
SE8106641L (sv) 1982-06-24
JPH07308191A (ja) 1995-11-28
NO165201C (no) 1991-01-16
NL8105078A (nl) 1982-06-01
JP2642291B2 (ja) 1997-08-20
EP0051873A3 (en) 1982-09-22
HK51685A (en) 1985-07-12
IT8124967A0 (it) 1981-11-10
KE3536A (en) 1985-06-07
GB2090258A (en) 1982-07-07
NZ198906A (en) 1985-12-13
GB2090258B (en) 1984-05-02
YU46597B (sh) 1994-01-20
MY8700710A (en) 1987-12-31
FR2493867B1 (fr) 1986-06-27
GR81947B (ja) 1984-12-12
CA1277616C (en) 1990-12-11
PT73955B (en) 1983-11-23
SE460539B (sv) 1989-10-23
AU7730481A (en) 1982-05-20
FI79550B (fi) 1989-09-29

Similar Documents

Publication Publication Date Title
IL64243A (en) Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them
HK49285A (en) Interferons and process for their preparation
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
ZA81975B (en) Microbiologically prepared polypeptide with the aminoacid sequence of human interferon, dna and plasmids which act as codings for this sequence, microorganisms which contain this genetic information, and processes for their preparation
NZ212937A (en) Omega interferons: production by recombinant dna processes; pharmaceutical compositions
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired